MK

Michael Kaplitt

TU The Rockefeller University: 7 patents #55 of 698Top 8%
NE Neurologix: 5 patents #2 of 8Top 25%
TU Thomas Jefferson University: 2 patents #147 of 538Top 30%
YU Yale University: 2 patents #418 of 1,662Top 30%
CU Cornell University: 1 patents #786 of 1,984Top 40%
ME Medtronic: 1 patents #4,185 of 6,325Top 70%
📍 New York, NY: #1,332 of 20,192 inventorsTop 7%
🗺 New York: #10,487 of 115,490 inventorsTop 10%
Overall (All Time): #352,168 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
8642341 Materials and methods for gene mediated therapy of psychiatric disorders Brian Alexander 2014-02-04
8182460 Infusion device and method for infusing material into the brain of a patient Matthew During 2012-05-22
8067156 Method for generating replication defective viral vectors that are helper free Sergei Moussatov 2011-11-29
8021838 Transcriptional regulation of target genes Matthew During, Andres M. Lozano 2011-09-20
8017385 Use of apotosis inhibiting compounds in degenerative neurological disorders Serguei Moussatov 2011-09-13
7955595 Glutamic acid decarboxylase (GAD) based delivery system Matthew During 2011-06-07
7695959 Glutamic acid decarboxylase (GAD) based delivery systems Matthew During 2010-04-13
7645446 Glutamic acid decarboxylase (GAD) based delivery system Matthew During 2010-01-12
6780409 Glutamic acid decarboxylase (GAD) based delivery system Matthew During 2004-08-24
6503888 AAV-mediated delivery of DNA to cells of the nervous system Matthew During 2003-01-07
6180613 AAV-mediated delivery of DNA to cells of the nervous system Matthew During 2001-01-30
6162796 Method for transferring genes to the heart using AAV vectors Martin J. Kaplitt, Edward Bronson DIETHRICH 2000-12-19
6106824 Expression of growth associated protein B-50/GAP-43 in vitro and in vivo Joost Verhaagen 2000-08-22
6040172 Defective DNA viral vector comprising a neural tissue-specific promoter for in vivo expression of a gene 2000-03-21